+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

USA Respiratory Disease Market 2024: Shares and Segment Forecasts - Adenovirus, Coronavirus, Enterovirus, Influenza, Legionella, Mononucleosis, Mycoplasma, Pneumonia, RSV, Rhinovirus, and Tuberculosis

  • PDF Icon

    Report

  • August 2024
  • Region: United States
  • VPG Market Research
  • ID: 5995563
This report provides analysis of the US respiratory disease testing market, including emerging technologies, instrumentation review, volume and sales segment forecasts by country, supplier shares, and strategic profiles of leading competitors.

About this Report

This report presents detailed analysis of the Respiratory Disease market in France.

Current scientific views on epidemiology and etiology are presented for:
  • Adenovirus
  • Coronavirus
  • Enterovirus
  • Influenza
  • Legionella
  • Mononucleosis
  • Mycoplasma
  • Pneumonia
  • RSV
  • Rhinovirus
  • Tuberculosis
The report provides test volume and sales forecasts by country and market segment.

In addition to market share and sales forecasts, the report:
  • Examines market applications of molecular diagnostics, monoclonal antibodies, immunoassays, IT and other technologies.
  • Reviews features and operating characteristics of major analyzers used for respiratory disease testing.
  • Profiles key suppliers and potential market entrants developing innovative technologies and products.
  • Analyzes emerging opportunities, alternative market penetration strategies, market entry barriers/risks, and strategic planning issues.
Methodology

In addition to primary sources of information, a comprehensive review of the most recent technical and business publications, manufacturer product and financial literature, as well as proprietary data files was conducted.